Who Paid My Doc
Clinton Morrison
Plastic and Reconstructive Surgery Rochester, NY Medical Doctor
NPI 1245433614 CMS profile 193294
601 Elmwood Ave, Rochester, NY 14642
General payments
$4,833
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Clinton Morrison of Rochester, NY is reported in the CMS Open Payments database as having received $4,833 across 19 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 68th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $190 | 3 | |
| 2024 | General | $82 | 2 | |
| 2023 | General | $203 | 3 | |
| 2022 | General | $2,191 | 7 | |
| 2020 | General | $1,950 | 2 | |
| 2019 | General | $217 | 2 |
Beside peers
- Clinton Morrison
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Clinton Morrison were reported at $190. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Clinton Morrison | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $217 | $335 | $121–$1,264 | $163 |
| 2020 | $1,950 | $162 | $57–$417 | $114 |
| 2021 | $0 | $245 | $89–$735 | $132 |
| 2022 | $2,191 | $325 | $120–$932 | $149 |
| 2023 | $203 | $343 | $129–$999 | $160 |
| 2024 | $82 | $390 | $141–$1,085 | $164 |
| 2025 | $190 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 11 billing codesPaid by Medicare
$2,995
Medicare patients
11
Services billed
14
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
19 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in New York
Howard Langstein
Plastic and Reconstructive Surgery · Rochester, NY
James Bradley
Plastic and Reconstructive Surgery · New Hyde Park, NY
Robert Grant
Plastic and Reconstructive Surgery · New York, NY
Christine Rohde
Plastic and Reconstructive Surgery · New York, NY
Steven Levine
Plastic and Reconstructive Surgery · New York, NY
Tara Huston
Plastic and Reconstructive Surgery · Stony Brook, NY
Related records
Plastic and Reconstructive Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.